临产妇预防性使用间苯三酚的临床价值

Abstract
Figure/Table
References
Related Citation (3)

Download: PDF (594 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the clinical value of prophylactic use of phloroglucinol in the incubation period. Methods From February 2014 to November 2014, a total of 100 full-term pregnant, monocyesis and primigravid women were recruited as study group, after regular contractions developed, they were given phloroglucinol 80 mg intravenously every 2 hours, twice a day at most . At the same time another 100 pregnant women were recruited as control group; they did not receive any disposal and et the labor naturally progress. Between two groups, the first, second and third stages of labor time, number of patients with cervix edema, transter number of cesarean section, 2 h bleeding roluml after delivery, neonatal Apgar score were compared. Results The first stage of labor in the study group was shortened obviously, the difference was statistically significant (P<0.05).The second and third stages of labor had no statistically significant difference (P<0.05).the cervix edema developed in 4 cases in the study group , 16 cases in the control group, the difference was statistically significant. In the study group and control group, 16 cases and 29 cases failed and turned to cesarean section; the difference was significant between the two groups (P<0.05). 2 h postpartum blood loss and neonatal Apgar score between the two groups were to significantly different. Conclusion Phloroglucinol as a safe spasmolytic medicine, also can be applied to the early clinical stage for prevention.This study confirmed that preventive use of phloroglucinol in the incubation period can effectively reduce the incidence rate of cervix edema, shorten the first stage of labor and reduce cesarean delivery rate; and has no adverse effect on mother and fetus.

Key words： phloroglucinol the incubation period

Received: 11 May 2015

ZTFLH:

R714.3

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	YAO Shourun
	and KONG Lingdan

Cite this article:

YAO Shourun,and KONG Lingdan. Using phloroglucinol in incubation period to promote the clinical effect on cervical maturity[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2016, 27(1): 15-17.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2016/V27/I1/15

[1]	王瑞华,顾成敏,魏东红.间苯三酚应用于产程不同时期的效果分析[J].中国妇幼保健,2012,27(33):5294-5296.
[2]	崔雅坤,卢志茹,李力.间苯三酚对无痛分娩产程影响的临床研究[J].河北医药,2015,37(14):2173-2174.
[3]	姚毓筠. 间苯三酚在妇产科的应用[J]. 医学综述,2011,17(14):2170-2172.
[4]	林伟斯.间苯三酚联合地西泮治疗潜伏期宫颈水肿疗效观察[J]. 现代诊断与治疗,2015,09(14):1979-1980.
[5]	乐杰. 妇产科学[M]. 6 版. 北京: 人民卫生出版社, 2005: 207.
[6]	董秀英,杨秋英,刘亚辉.间苯三酚在瘢痕子宫再次足月妊娠阴道试产过程中的临床应用[J]. 世界最新医学信息文摘,2015,15(24):140-141.
[7]	聂素娟,杨美霞.间苯三酚联合催产素在产妇自然分娩中的作用[J].海峡药学,2012,24(9):102-103.
[8]	吴敏君,祝佳,李文佼,等.间苯三酚应用于第一产程的临床观察[J].医学综述,2012,18(10):1593-1595.
[9]	吴霞,翟桂荣,黄醒华.潜伏期应用间苯三酚对第一产程的影响[J].中华围产医学杂志,2005,8(3):150-153.
[10]	尉蔚,申彩霞.斯帕丰药物在产程活跃期的应用[J].中国优生与遗传杂志,2005,13(5):77-83.
[11]	袁海琳.应用间苯三酚治疗分娩时宫颈水肿的临床观察[J].中国医药指南,2013,10(17):132-133.
[12]	李慧英.间苯三酚在临床治疗宫颈水肿方面的应用[J].中国现代药学应用,2014,08(24):136-137.
[13]	王凤珍.间苯三酚在第一产程中的应用[J].齐齐哈尔医学院学报,2014,35(22):3347-3348.
[14]	乔春红.间苯三酚对产程影响的临床观察[J].北方药学,2014,11(12):69.
[15]	郭琴.产科分娩中联用间苯三酚用于活跃期减轻痛觉的临床观察[J].中国医学工程,2014,22(11):26.
[16]	尹璐,张瑜,刘大庆.应用间苯三酚治疗产程活跃期宫颈水肿的临床观察[J].中国计划生育和妇产科,2014,6(9):58-60.